Sherwin-Williams (NYSE:SHW) PT Raised to $360.00 at Robert W. Baird

Sherwin-Williams (NYSE:SHW) had its target price upped by stock analysts at Robert W. Baird from $350.00 to $360.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the specialty chemicals company’s stock. Robert W. Baird’s target price would suggest a potential downside of 0.35% from the stock’s current price.

A number of other brokerages also recently commented on SHW. The Goldman Sachs Group increased their price target on shares of Sherwin-Williams from $344.00 to $390.00 and gave the company a “buy” rating in a report on Wednesday, July 24th. Barclays raised their price objective on Sherwin-Williams from $315.00 to $355.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 24th. Evercore ISI boosted their target price on Sherwin-Williams from $365.00 to $380.00 and gave the company an “outperform” rating in a research report on Friday, August 30th. Royal Bank of Canada restated an “outperform” rating and issued a $418.00 price target on shares of Sherwin-Williams in a research report on Friday, August 30th. Finally, Wells Fargo & Company boosted their price objective on shares of Sherwin-Williams from $350.00 to $400.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 15th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $385.41.

Sherwin-Williams Stock Performance

SHW opened at $361.27 on Wednesday. The company has a debt-to-equity ratio of 2.17, a quick ratio of 0.50 and a current ratio of 0.81. The stock has a market capitalization of $91.13 billion, a price-to-earnings ratio of 36.83, a PEG ratio of 3.04 and a beta of 1.17. The company has a fifty day moving average of $371.59 and a 200 day moving average of $334.45. Sherwin-Williams has a fifty-two week low of $232.06 and a fifty-two week high of $392.57.

Sherwin-Williams (NYSE:SHW) last issued its quarterly earnings data on Tuesday, October 22nd. The specialty chemicals company reported $3.37 earnings per share for the quarter, missing analysts’ consensus estimates of $3.55 by ($0.18). The firm had revenue of $6.16 billion for the quarter, compared to analysts’ expectations of $6.20 billion. Sherwin-Williams had a net margin of 10.92% and a return on equity of 75.58%. The company’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.20 EPS. As a group, sell-side analysts forecast that Sherwin-Williams will post 11.49 earnings per share for the current fiscal year.

Insider Activity

In other Sherwin-Williams news, CFO Allen J. Mistysyn sold 14,520 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the transaction, the chief financial officer now directly owns 63,520 shares in the company, valued at $23,301,041.60. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Sherwin-Williams

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Tamar Securities LLC boosted its position in Sherwin-Williams by 3.4% during the 3rd quarter. Tamar Securities LLC now owns 48,753 shares of the specialty chemicals company’s stock valued at $18,608,000 after acquiring an additional 1,604 shares in the last quarter. Valeo Financial Advisors LLC raised its holdings in Sherwin-Williams by 7.9% in the second quarter. Valeo Financial Advisors LLC now owns 2,636 shares of the specialty chemicals company’s stock worth $787,000 after purchasing an additional 193 shares in the last quarter. Transcend Capital Advisors LLC lifted its position in shares of Sherwin-Williams by 24.1% during the second quarter. Transcend Capital Advisors LLC now owns 7,805 shares of the specialty chemicals company’s stock valued at $2,329,000 after buying an additional 1,514 shares during the last quarter. Handelsbanken Fonder AB boosted its holdings in shares of Sherwin-Williams by 4.3% in the 3rd quarter. Handelsbanken Fonder AB now owns 98,118 shares of the specialty chemicals company’s stock valued at $37,449,000 after buying an additional 4,074 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S boosted its holdings in shares of Sherwin-Williams by 17.3% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 20,592 shares of the specialty chemicals company’s stock valued at $7,152,000 after buying an additional 3,031 shares in the last quarter. 77.67% of the stock is currently owned by institutional investors.

Sherwin-Williams Company Profile

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.